These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25775640)

  • 1. Management of Onychomycosis in Canada in 2014.
    Gupta AK; Paquet M
    J Cutan Med Surg; 2015; 19(3):260-73. PubMed ID: 25775640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciclopirox nail lacquer: a brush with onychomycosis.
    Gupta AK
    Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapies for the treatment of onychomycosis.
    Gupta AK; Paquet M; Simpson FC
    Clin Dermatol; 2013; 31(5):544-54. PubMed ID: 24079583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK; Simpson FC
    Skin Therapy Lett; 2014; 19(1):1-4. PubMed ID: 24570290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis: Current trends in diagnosis and treatment.
    Westerberg DP; Voyack MJ
    Am Fam Physician; 2013 Dec; 88(11):762-70. PubMed ID: 24364524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclopirox nail lacquer and podiatric practice.
    Gupta AK; Malkin KF
    J Am Podiatr Med Assoc; 2000; 90(10):502-7. PubMed ID: 11107711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onychomycosis: Treatment and prevention of recurrence.
    Lipner SR; Scher RK
    J Am Acad Dermatol; 2019 Apr; 80(4):853-867. PubMed ID: 29959962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclopirox nail lacquer solution 8% in the 21st century.
    Gupta AK; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S96-102. PubMed ID: 11051138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of toenail onychomycosis.
    Tom CM; Kane MP
    Am J Health Syst Pharm; 1999 May; 56(9):865-71. PubMed ID: 10344609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onychomycosis: recognition, diagnosis, and management.
    Jaffe R
    Arch Fam Med; 1998; 7(6):587-92. PubMed ID: 9821836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical and surgical treatment of onychomycosis.
    Cohen PR; Scher RK
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S74-7. PubMed ID: 8077513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Timeline of Onychomycosis Therapy and Future Directions.
    Geizhals S; Lipner SR
    Skinmed; 2020; 18(6):367-371. PubMed ID: 33397567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.
    Evans EG
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S32-36. PubMed ID: 9594934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How effective is efinaconazole in the management of onychomycosis?
    Gupta AK; Cernea M
    Expert Opin Pharmacother; 2016; 17(4):611-8. PubMed ID: 26809447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis: a review.
    Gupta AK; Stec N; Summerbell RC; Shear NH; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1972-1990. PubMed ID: 32239567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.
    Cribier BJ; Bakshi R
    Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.